Overview Dividends

(DAVA) Endava - Ratings and Ratios

Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US29260V1052

Digital Strategy, Cloud Engineering, AI Platforms, Managed Services

DAVA EPS (Earnings per Share)

EPS Growth (3Y CAGR): -69.80%
EPS Trend (3Y Correlation): -91.7%

DAVA Revenue

Revenue Growth (3Y CAGR): -1.77%
Revenue Trend (3Y Correlation): -31.3%

Description: DAVA Endava October 21, 2025

Endava plc (NYSE:DAVA) is a UK-based technology services firm operating across North America, Europe, the United Kingdom and globally, delivering a suite of digital-product acceleration, advisory, delivery, engineering, data-AI, and managed-services capabilities to a broad set of industries.

In FY 2023 the company reported revenue of approximately $1.2 billion, representing a 14 % year-over-year increase, and an operating margin near 13 %, reflecting the higher-margin nature of its consulting and engineering work. Its backlog stood at roughly $1.6 billion, indicating a strong pipeline of multi-year contracts.

Key economic drivers for Endava include sustained corporate spending on digital transformation-especially in financial services and healthcare-wherein low-interest-rate environments and regulatory pressure are prompting accelerated adoption of cloud, AI, and automation solutions. Additionally, the near-shoring trend toward Europe and the U.S. is boosting demand for the firm’s distributed-agile delivery model.

For a deeper quantitative look at Endava’s valuation metrics, the ValueRay platform offers a concise, data-driven dashboard worth exploring.

DAVA Stock Overview

Market Cap in USD	466m
Sub-Industry	IT Consulting & Other Services
IPO / Inception	2018-07-27

DAVA Stock Ratings

Growth Rating	-91.8%
Fundamental	45.5%
Dividend Rating	-
Return 12m vs S&P 500	-70.7%
Analyst Rating	3.92 of 5

DAVA Dividends

Currently no dividends paid

DAVA Growth Ratios

Growth Correlation 3m	-86.2%
Growth Correlation 12m	-91.9%
Growth Correlation 5y	-86.5%
CAGR 5y	-51.54%
CAGR/Max DD 3y (Calmar Ratio)	-0.57
CAGR/Mean DD 3y (Pain Ratio)	-0.95
Sharpe Ratio 12m	-0.56
Alpha	-85.27
Beta	1.151
Volatility	53.56%
Current Volume	534.8k
Average Volume 20d	963.1k
Stop Loss	8.2 (-5.9%)
Signal	-0.01

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (21.2m TTM) > 0 and > 6% of Revenue (6% = 46.3m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 20.74% (prev 15.36%; Δ 5.38pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 52.8m > Net Income 21.2m (YES >=105%, WARN >=100%)

Net Debt (168.7m) to EBITDA (79.8m) ratio: 2.12 <= 3.0 (WARN <= 3.5)

Current Ratio 2.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (59.4m) change vs 12m ago 1.08% (target <= -2.0% for YES)

Gross Margin 25.08% (prev 24.26%; Δ 0.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 79.22% (prev 73.06%; Δ 6.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.25 (EBITDA TTM 79.8m / Interest Expense TTM 10.7m) >= 6 (WARN >= 3)

Altman Z'' 5.09

(A) 0.17 = (Total Current Assets 281.9m - Total Current Liabilities 121.7m) / Total Assets 935.8m

(B) 0.61 = Retained Earnings (Balance) 575.4m / Total Assets 935.8m

(D) 1.64 = Book Value of Equity 579.6m / Total Liabilities 352.8m

Total Rating: 5.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 45.52

1. Piotroski 5.50pt = 0.50

2. FCF Yield 9.30% = 4.65

3. FCF Margin 6.22% = 1.56

4. Debt/Equity 0.39 = 2.42

5. Debt/Ebitda 2.12 = -0.23

6. ROIC - WACC (= -5.38)% = -6.73

7. RoE 3.38% = 0.28

8. Rev. Trend -31.34% = -2.35

9. EPS Trend -91.70% = -4.59

What is the price of DAVA shares?

As of October 24, 2025, the stock is trading at USD 8.71 with a total of 534,786 shares traded.
Over the past week, the price has changed by +2.23%, over one month by -5.02%, over three months by -42.55% and over the past year by -65.52%.

Is Endava a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Endava (NYSE:DAVA) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.52 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DAVA is around 4.16 USD . This means that DAVA is currently overvalued and has a potential downside of -52.24%.

Is DAVA a buy, sell or hold?

Endava has received a consensus analysts rating of 3.92. Therefore, it is recommended to buy DAVA.

Strong Buy: 5
Buy: 1
Hold: 6
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the DAVA price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	17.3	98.3%
Analysts Target Price	17.3	98.3%
ValueRay Target Price	4.6	-47.5%

DAVA Fundamental Data Overview October 17, 2025

Market Cap GBP = 348.6m (466.1m USD * 0.7478 USD.GBP)
P/E Trailing = 18.0417
P/E Forward = 11.1857
P/S = 0.6036
P/B = 0.6358
P/EG = 0.6778
Beta = 1.151
Revenue TTM = 772.3m GBP
EBIT TTM = 34.8m GBP
EBITDA TTM = 79.8m GBP
Long Term Debt = 180.9m GBP (from longTermDebt, last quarter)
Short Term Debt = 13.7m GBP (from shortTermDebt, last quarter)
Debt = 228.1m GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 168.7m GBP (from netDebt column, last quarter)
Enterprise Value = 517.2m GBP (348.6m + Debt 228.1m - CCE 59.5m)
Interest Coverage Ratio = 3.25 (Ebit TTM 34.8m / Interest Expense TTM 10.7m)
FCF Yield = 9.30% (FCF TTM 48.1m / Enterprise Value 517.2m)
FCF Margin = 6.22% (FCF TTM 48.1m / Revenue TTM 772.3m)
Net Margin = 2.75% (Net Income TTM 21.2m / Revenue TTM 772.3m)
Gross Margin = 25.08% ((Revenue TTM 772.3m - Cost of Revenue TTM 578.6m) / Revenue TTM)
Gross Margin QoQ = 24.86% (prev 27.50%)
Tobins Q-Ratio = 0.55 (Enterprise Value 517.2m / Total Assets 935.8m)
Interest Expense / Debt = 4.69% (Interest Expense 10.7m / Debt 228.1m)
Taxrate = 69.26% (2.63m / 3.80m)
NOPAT = 10.7m (EBIT 34.8m * (1 - 69.26%))
Current Ratio = 2.32 (Total Current Assets 281.9m / Total Current Liabilities 121.7m)
Debt / Equity = 0.39 (Debt 228.1m / totalStockholderEquity, last quarter 582.9m)
Debt / EBITDA = 2.12 (Net Debt 168.7m / EBITDA 79.8m)
Debt / FCF = 3.51 (Net Debt 168.7m / FCF TTM 48.1m)
Total Stockholder Equity = 627.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.27% (Net Income 21.2m / Total Assets 935.8m)
RoE = 3.38% (Net Income TTM 21.2m / Total Stockholder Equity 627.4m)
RoCE = 4.31% (EBIT 34.8m / Capital Employed (Equity 627.4m + L.T.Debt 180.9m))
RoIC = 1.39% (NOPAT 10.7m / Invested Capital 770.8m)
WACC = 6.77% (E(348.6m)/V(576.6m) * Re(10.26%) + D(228.1m)/V(576.6m) * Rd(4.69%) * (1-Tc(0.69)))
Discount Rate = 10.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.71%
[DCF Debug] Terminal Value 69.00% ; FCFE base≈48.4m ; Y1≈44.5m ; Y5≈39.9m
Fair Price DCF = 12.35 (DCF Value 503.7m / Shares Outstanding 40.8m; 5y FCF grow -10.11% → 3.0% )
EPS Correlation: -91.70 | EPS CAGR: -69.80% | SUE: -0.10 | # QB: 0
Revenue Correlation: -31.34 | Revenue CAGR: -1.77% | SUE: 0.00 | # QB: 0

Additional Sources for DAVA Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle